Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-8,480
Closed -$2.18M 101
2021
Q3
$2.18M Buy
8,480
+1,820
+27% +$524K 1.03% 35
2021
Q2
$1.86M Sell
6,660
-3,900
-37% -$872K 0.85% 37
2021
Q1
$2.14M Sell
10,560
-255
-2% -$59.1K 1.11% 33
2020
Q4
$2.4M Sell
10,815
-5,390
-33% -$1.21M 1.27% 28
2020
Q3
$3.49M Sell
16,205
-5,952
-27% -$1.24M 2.13% 17
2020
Q2
$3.82M Buy
22,157
+1,440
+7% +$181K 2.68% 12
2020
Q1
$1.91M Buy
+20,717
New +$1.67M 2.72% 15

Other funds holding DOCU

Geneva Partners's DOCU Position: Q4 2021 in Review

Geneva Partners sold out of DocuSign (DOCU) in Q4 2021, closing a stake of 8,480 shares — an estimated $2.18M sold.

Geneva Partners first reported a position in DOCU in Q1 2020 and held it in 7 quarters. The position peaked at $3.82M in Q2 2020. 1,008 funds tracked by Wall St. Rank hold DOCU as of Q4 2021.

  • Geneva Partners reported no remaining DocuSign position as of Q4 2021 after selling out during the quarter.
  • Geneva Partners sold 8,480 DocuSign shares in Q4 2021, an estimated $2.18M.
  • Geneva Partners first reported a position in DocuSign in Q1 2020 and held it in 7 quarters.
  • Geneva Partners's DocuSign position peaked at $3.82M in Q2 2020.
  • 1,008 funds tracked by Wall St. Rank held DocuSign as of Q4 2021.

Based on Geneva Partners's 13F filing for Q4 2021, filed 31 Jan 2022.